Dzjemma Sarkisjan

Statistics

Publications

Citations

611

H-Index

Active since

2013

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Psyadon Pharmaceuticals (United States)

Dzjemma Sarkisjan is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in drug discovery, pharmacology, and natural sciences.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesMolecular BiologyMetabolismBiochemistryCell BiologyTumor BiologyCancer Biology

Publications per year

2013–2019

Publications

Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment

Anne Dirkse, Anna Golebiewska, Thomas Buder et al. · Nature Communications · 2019 · 525 citations · Full text

Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360)

Godefridus J. Peters, Kees Smid, Leonardo Vecchi et al. · Investigational New Drugs · 2013 · 35 citations

Molecular Pharmacology, Biochemistry, Medicine +10

The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2

Dzjemma Sarkisjan, Joris R. Julsing, Kees Smid et al. · PLoS ONE · 2016 · 30 citations · Full text

Chemoprevention Strategy, Uridine-cytidine Kinase 2, Uck2-mrna Expression +21

DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.

Richard J. Honeywell, Dzjemma Sarkisjan, Michael Holmsgaard Kristensen et al. · Nucleosides Nucleotides & Nucleic Acids · 2018 · 21 citations · Full text

1–4 of 4